Researchers have developed a novel non-invasive test for nasopharyngeal carcinoma that uses automated analysis of bilateral nasal swab DNA methylation biomarkers. Published in BMC Cancer, this method promises earlier and less intrusive diagnosis of nasopharyngeal cancer, potentially improving screening and patient outcomes in high-risk populations. The approach exemplifies advances in epigenetic biomarker applications for oncology diagnostics.